A multicentre, double blind, randomised, placebo-controlled, Phase II trial to evaluate Resminostat for maintenance treatment of patients with advanced stage (Stage IIB-IVB) mycosis fungoides (MF) or Sézary Syndrome (SS) that have achieved disease control with systemic therapy – the RESMAIN Study - Projekt - KSSG Forschungsdatenbank

Projekt

A multicentre, double blind, randomised, placebo-controlled, Phase II trial to evaluate Resminostat for maintenance treatment of patients with advanced stage (Stage IIB-IVB) mycosis fungoides (MF) or Sézary Syndrome (SS) that have achieved disease control with systemic therapy – the RESMAIN Study

Laufend - Rekrutierung – beendet · 2016 bis 2027

Cozzio Antonio

Art

Klinische Forschung

Reichweite

Multizentrisch, KSSG als teilnehmendes Zentrum

Bereiche

Dermatologie | Venerologie | Allergologie

Status

Laufend - Rekrutierung – beendet

Start

2016

Ende

2027

Finanzierungsart

Industrie

Label

Lymphom

Kurzbeschreibung/Zielsetzung